Curcumin nanoparticles and the therapeutic potential of curcumin for musculoskeletal disorders.
Eur Rev Med Pharmacol Sci
; 27(20): 9680-9702, 2023 Oct.
Article
en En
| MEDLINE
| ID: mdl-37916332
Musculoskeletal disorders (MSD) are a collection of degenerative conditions impacting the body's bones, joints, muscles, tendons, ligaments, and nerves. MSDs affect approximately 1.71 billion individuals worldwide and are a significant cause of disability. Curcumin is a polyphenolic compound with anti-inflammatory, antioxidant, and antitumor properties. In this review, we will discuss the research progress of structural analogs, derivatives, and nanomaterials that can improve the bioavailability of this natural drug. Curcumin may potentially retard the progression of osteoporosis, osteoarthritis, and rheumatoid arthritis. These effects may be related to curcumin's targeting of multiple signalling pathways.
Texto completo:
1
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Terapias_biologicas
/
Aromoterapia
/
Plantas_medicinales
Asunto principal:
Osteoartritis
/
Enfermedades Musculoesqueléticas
/
Curcumina
/
Nanopartículas
Idioma:
En
Revista:
Eur Rev Med Pharmacol Sci
Año:
2023
Tipo del documento:
Article
País de afiliación:
China